Tumor necrosis factor-alpha levels gurrelate with a better response to adalimumab in patients with rheumatoid arthritis

被引：0
|
作者：
Cuchacovich, M.
Soto, L.
Gutierrez, M.
Llanos, C.
Sabugo, F.
Pacheco, D.
Alamos, M.
Fuentealba, C.
Villanueva, L.
Gatica, H.
Schiattino, I.
Salazar, L.
Catalan, D.
Valenzuela, O.
Salazar-Onfray, F.
Aguillon, J.
机构：
[1] Univ Chile, Hosp Clin, Dept Med, Rheumatol Sect, Santiago, Chile
[2] Catholic Univ Chile, Hosp Clin, Dept Med, Div Rheumatol, Santiago, Chile
[3] Univ Chile, San Borja Arriaran Hosp, Dept Med, Santiago, Chile
[4] Univ Chile, Fac Med, ICBM, Program Discplinary Immunol, Santiago, Chile
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [21] All-Cause Mortality Associated with Tumor Necrosis Factor-Alpha Inhibitor in Patients with Rheumatoid Arthritis
    Kawada, Tomoyuki
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (09): : E217 - E217
  • [22] Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis.
    Setoguchi, S.
    Schneeweiss, S.
    Avorn, J.
    Katz, J. N.
    Weinblatt, M. E.
    Levin, R.
    Solomon, D. H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S38 - S38
  • [23] Tumor Necrosis Factor-Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis: A Systematic Review
    Nair, Shaalina
    Kahlon, Simranjit Singh
    Sikandar, Rabia
    Peddemul, Aishwarya
    Tejovath, Sreedevi
    Hassan, Danial
    Patel, Khushbu K.
    Mostafa, Jihan A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [24] Active Tuberculosis in a Patient with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-Alpha Inhibitor
    Fuchs, Inbal
    Abu-Shakra, Mahmoud
    Gelfer, Eugenia
    Smoliakov, Alexander
    Ben-Haroch, Daniel
    Horowitz, Jacob
    Avnon, Lone S.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2010, 12 (09): : 579 - 581
  • [25] Miliary tuberculosis in a patient with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitor
    Aoyama, Sayaka
    Kano, Yasuhiro
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 366 (03): : E38 - E39
  • [26] Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Ted R. Mikuls
    Arthur L. Weaver
    Current Rheumatology Reports, 2003, 5 (4) : 270 - 277
  • [27] Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis
    Kageyama, Yasunori
    Torikai, Eiji
    Nagano, Akira
    RHEUMATOLOGY INTERNATIONAL, 2007, 27 (05) : 467 - 472
  • [28] Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis
    Yasunori Kageyama
    Eiji Torikai
    Akira Nagano
    Rheumatology International, 2007, 27 : 467 - 472
  • [29] Tumour necrosis factor (TNF)α-308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis
    Cuchacovich, M.
    Soto, L.
    Edwardes, M.
    Gutierrez, M.
    Llanos, C.
    Pacheco, D.
    Sabugo, F.
    Alamo, M.
    Fuentealba, C.
    Villanueva, L.
    Gatica, H.
    Schiattino, I.
    Salazar, L.
    Catalan, D.
    Valenzuela, O.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 (06) : 435 - 440
  • [30] MARKED INCREASE IN SLEEP DURATION AND QUALITY IN PATIENTS WITH RHEUMATOID ARTHRITIS BY ETANERCEPT, A TUMOR NECROSIS FACTOR-ALPHA ANTAGONIST
    Blau, A.
    Dziurla, R.
    Detert, J.
    Schoebel, C.
    Buttgereit, F.
    Fietze, I
    SLEEP, 2010, 33 : A7 - A7
12345